Expression and significance of P53,Bcl-2 and Bax in bladder cancer
Guo We
Abstract
Guo We
Abstract
Objective To investigate the expression and significance of P53,Bcl-2 and Bax proteins in bladder cancer. Methods Immunohistochemical technique( SP) was adopted to detect the expression of P53,Bcl-2 and Bax proteins in 67 cases of bladder cancer and 13 cases of normal bladder mucosa tissues. Results The positive expression rates of P53,Bcl-2 and Bax proteins were 74. 6%, 64. 2% and 70. 1% in bladder cancer,and 15. 4%,23. 1%,100% in normal bladder mucosa tissues,respectively. The expression of P53 and Bcl-2 in bladder cancer was positively associated with histological grade( rP53= 0. 667,rBcl-2= 0. 625,P 0. 05) and clinical stages( rP53= 0. 638,rBcl-2= 0. 717,P 0. 05). The expression of Bax was not correlated with histological grade and clinical stage( P 0. 05). There was a positive correlation between the expression of P53 and Bcl-2 in bladder cancer( r = 0. 778,P 0. 05). Conclusion P53 protein may participate in regulating the cell proliferation in bladder cancer,and Bcl-2,Bax protein may be involved in the regulation of apoptosis. The expression of P53 protein may participate in the development and progression of bladder cancer by increasing anti-apoptotic protein Bcl-2 expression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the expression and significance of P53,Bcl-2 and Bax proteins in bladder cancer. Methods Immunohistochemical technique( SP) was adopted to detect the expression of P53,Bcl-2 and Bax proteins in 67 cases of bladder cancer and 13 cases of normal bladder mucosa tissues. Results The positive expression rates of P53,Bcl-2 and Bax proteins were 74. 6%, 64. 2% and 70. 1% in bladder cancer,and 15. 4%,23. 1%,100% in normal bladder mucosa tissues,respectively. The expression of P53 and Bcl-2 in bladder cancer was positively associated with histological grade( rP53= 0. 667,rBcl-2= 0. 625,P 0. 05) and clinical stages( rP53= 0. 638,rBcl-2= 0. 717,P 0. 05). The expression of Bax was not correlated with histological grade and clinical stage( P 0. 05). There was a positive correlation between the expression of P53 and Bcl-2 in bladder cancer( r = 0. 778,P 0. 05). Conclusion P53 protein may participate in regulating the cell proliferation in bladder cancer,and Bcl-2,Bax protein may be involved in the regulation of apoptosis. The expression of P53 protein may participate in the development and progression of bladder cancer by increasing anti-apoptotic protein Bcl-2 expression.
Key concepts: Bladder cancer, Immunohistochemistry, BAX Protein, Apoptosis, P53 protein, Bladder Neoplasm, Cancer, Cancer research